Kim has over 35 years of U.S. medical device sales, marketing and operational experience in multi-national and start-up companies. She spent 16 years with Boehringer Mannheim/Roche Diagnostics where she held multiple positions in sales and marketing including P&L responsibility for a $100 million diabetes care diagnostics business.

The balance of her career has been dedicated to leading start-up medical device organizations with game-changing medical technologies including BioStar, Inc., a diagnostics company sold to Thermo Electron (NYSE:TMO), Medingo, Ltd, an Israeli insulin patch pump company acquired by Roche Holdings AG (ROG.VX), Anodyne Therapy, an infrared light therapy pain management company, and as President for GlycoMark, Inc., a start-up diabetes subsidiary of Toyota Tsusho America and DYSIS Medical, a UK-based women’s health company.

Kim has been Director of Mentoring for the Healthcare Businesswomen’s Association and in 2015, earned recognition as the Tampa Bay Businesswoman of the Year in the Health and Wellness category. She currently serves as an advisor to a number of start-ups at FIBA, the Tampa Bay WaVE and University of Tampa to develop strategies around sales, marketing, regulatory compliance, clinical study and KOL strategy, insurance reimbursement and distribution to all healthcare markets including hospitals, integrated delivery networks, physician office, home health care, long term care, physical therapy, retail/OTC and managed care/payers. She holds a B.S. in Biology, where she graduated summa cum laude from from St. Lawrence University.

Kim Linker Stebbing’s LinkedIn.